$7.22 1.1%
NUS Stock Price vs. AI Score
Data gathered: November 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Nu Skin

Nu Skin Enterprises Inc is a health and beauty direct-selling company with a comprehensive product line: anti-aging skin products; peels, masks, and scrubs; moisturizers; body care; hair care; men's care; oral care; sun protection; and cosmetics. The company has three main product divisions: anti-aging, skin, and pharmaceuticals. The pharmaceuticals division offers nutritionals, weight-management products, and food supplements. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.


Nu Skin
Price $7.22
Target Price Sign up
Volume 649,870
Market Cap $363M
Year Range $6.07 - $13.74
Dividend Yield 3.29%
PE Ratio 73.06
Analyst Rating 0% buy
Industry Cosmetics

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24430M413M301M8.3M20M0.170
Q2 '24439M416M307M-118M-124M0.210
Q1 '24408M402M294M-530,0009.2M0.090
Q4 '23462M468M352M7.3M47M0.370
Q3 '23499M526M292M-37M-33M0.560

Insider Transactions View All

LIPMAN ANDREW D filed to sell 23,225 shares at $13.3.
May 28 '24
WOODBURY EDWINA D filed to sell 18,095 shares at $12.
May 3 '24
LIPMAN ANDREW D filed to sell 25,225 shares at $12.3.
April 25 '24
LIPMAN ANDREW D filed to sell 27,225 shares at $12.3.
March 25 '24
LIPMAN ANDREW D filed to sell 29,225 shares at $12.5.
February 27 '24

What is the Market Cap of Nu Skin?

The Market Cap of Nu Skin is $363M.

What is Nu Skin's PE Ratio?

As of today, Nu Skin's PE (Price to Earnings) ratio is 73.06.

What is the current stock price of Nu Skin?

Currently, the price of one share of Nu Skin stock is $7.22.

How can I analyze the NUS stock price chart for investment decisions?

The NUS stock price chart above provides a comprehensive visual representation of Nu Skin's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Nu Skin shares. Our platform offers an up-to-date NUS stock price chart, along with technical data analysis and alternative data insights.

Does NUS offer dividends to its shareholders?

Yes, Nu Skin (NUS) offers dividends to its shareholders, with a dividend yield of 3.29%. This dividend yield represents Nu Skin's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Nu Skin in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Nu Skin?

Some of the similar stocks of Nu Skin are Sally Beauty, Ulta Beauty, e.l.f. Cosmetics, Olaplex, and Estée Lauder.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.